Mivacron en es it fr

Mivacron Brand names, Mivacron Analogs

Mivacron Brand Names Mixture

  • No information avaliable

Mivacron Chemical_Formula


Mivacron RX_link


Mivacron fda sheet

Mivacron FDA

Mivacron msds (material safety sheet)

Mivacron MSDS

Mivacron Synthesis Reference

No information avaliable

Mivacron Molecular Weight

228.286 g/mol

Mivacron Melting Point

No information avaliable

Mivacron H2O Solubility

Practically insoluble

Mivacron State


Mivacron LogP


Mivacron Dosage Forms

Tablets for oral administration (500 mg or 750 mg)

Mivacron Indication

For acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis.

Mivacron Pharmacology

Nabumetone is a naphthylalkanone. It is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic and antipyretic properties in pharmacologic studies. As with other nonsteroidal anti-inflammatory agents, its mode of action is not known. However, the ability to inhibit prostaglandin synthesis may be involved in the anti-inflammatory effect.

Mivacron Absorption

Well absorbed from the gastrointestinal tract. Coadministration of food increases the rate of absorption and subsequent appearance of 6MNA (the active metabolite) in the plasma but does not affect the extent of conversion of nabumetone into 6MNA.

Mivacron side effects and Toxicity

The one overdose occurred in a 17-year-old female patient who had a history of abdominal pain and was hospitalized for increased abdominal pain following ingestion of 30 nabumetone tablets (15 grams total). Stools were negative for occult blood and there was no fall in serum hemoglobin concentration. The patient had no other symptoms.

Mivacron Patient Information

Mivacron Organisms Affected

Humans and other mammals